MoonLake Immunotherapeutics (MLTX)
US$ 43.65-5.09%
Price Chart
Key Statistics
Market Cap
$ 2.35B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
289.23K
52W High
$ 58.26
52W Low
$ 31.42
Dividend Yield
0.00%
Beta
1.30
Technicals
50-Day MA
38.6022
200-Day MA
45.9213
52 Week High
58.26
52 Week Low
31.4201
About MLTX
MoonLake Immunotherapeutics, a clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and .
Employees
100
Headquarters
Zug, Switzerland
CEO
Dr. Jorge Santos da Silva Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg